sotyktu - deucravacitinib tablet, film coated
(Deucravacitinib)E.R. Squibb & Sons, L.L.C.
Usage: Sotyktu (TYK2 inhibitor) treats moderate-to-severe plaque psoriasis in adults eligible for systemic therapy or phototherapy, and active psoriatic arthritis in adults. Not recommended with other potent immunosuppressants.